C vs OKUR · P/E 16, rev $85.22B vs P/E 72, $76.6M cap
Citigroup Inc. (C) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
Citigroup Inc. (C) is a banks - diversified company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.
Latest reported OKUR revenue for 2024-12-31 was $0. Net income was -$52.7M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
C currently screens at market cap $214.73B and trailing P/E 15.5. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the C and OKUR stock pages for the full models.
Not investment advice.